22q11.2 deletion syndrome (22q11DS) is a clinically heterogeneous genetic syndrome, associated with a wide array of neuropsychiatric symptoms. The clinical presentation is likely to be influenced by environmental factors, yet little is known about this. Here, we review the available research literature on the role of the environment in 22q11DS. We find that within-patient design studies have mainly investigated the role of parental factors, stress, and substance use, reporting significant effects of these factors on the clinical profile. Case-control studies have been less successful, with almost no reports of significant moderating effects of the environment. We go on to hypothesize which specific environmental measures are most likely to ...
22q11.2 Deletion syndrome (22q11.2DS) is associated with high rates of schizophrenia, other neuropsy...
It is now well recognized that as well as having a characteristic facial dysmorphology and a range o...
Objective: Chromosome 22q11.2 deletion syndrome is a neurogenetic disorder associated with high rate...
22q11.2 deletion syndrome (22q11DS) is a clinically heterogeneous genetic syndrome, associated with ...
22q11.2 deletion syndrome (22q11DS) is a clinically heterogeneous genetic syndrome, associated with ...
Although approximately 1 in 4 people is affected by mental disorders at some point in their lives, t...
22q11.2 deletion syndrome is characterised by a well defined microdeletion that is associated with a...
ObjectiveChromosome 22q11.2 deletion syndrome is a neurogenetic disorder associated with high rates ...
22q11.2 deletion syndrome (22q11DS) is recognized as one of the strongest genetic risk factors for t...
Introduction: The 22q11.2 deletion syndrome is a genetic disorder with variable clinical manifestati...
OBJECTIVE Chromosome 22q11.2 deletion syndrome is a neurogenetic disorder associated with high rates...
Objective Chromosome 22q11.2 deletion syndrome is a neurogenetic disorder associated with high rates...
22q11.2 Deletion syndrome (22q11.2DS) is associated with high rates of schizophrenia, other neuropsy...
It is now well recognized that as well as having a characteristic facial dysmorphology and a range o...
Objective: Chromosome 22q11.2 deletion syndrome is a neurogenetic disorder associated with high rate...
22q11.2 deletion syndrome (22q11DS) is a clinically heterogeneous genetic syndrome, associated with ...
22q11.2 deletion syndrome (22q11DS) is a clinically heterogeneous genetic syndrome, associated with ...
Although approximately 1 in 4 people is affected by mental disorders at some point in their lives, t...
22q11.2 deletion syndrome is characterised by a well defined microdeletion that is associated with a...
ObjectiveChromosome 22q11.2 deletion syndrome is a neurogenetic disorder associated with high rates ...
22q11.2 deletion syndrome (22q11DS) is recognized as one of the strongest genetic risk factors for t...
Introduction: The 22q11.2 deletion syndrome is a genetic disorder with variable clinical manifestati...
OBJECTIVE Chromosome 22q11.2 deletion syndrome is a neurogenetic disorder associated with high rates...
Objective Chromosome 22q11.2 deletion syndrome is a neurogenetic disorder associated with high rates...
22q11.2 Deletion syndrome (22q11.2DS) is associated with high rates of schizophrenia, other neuropsy...
It is now well recognized that as well as having a characteristic facial dysmorphology and a range o...
Objective: Chromosome 22q11.2 deletion syndrome is a neurogenetic disorder associated with high rate...